Literature DB >> 27888319

Subacute cutaneous lupus erythematosus inducing unilateral sensorimotor neuropathy.

Savvas Psarelis1,2, Fanourios Georgiades3,4, Antreas Ioannou5, Eleni Xenophontos5, Georgios Georgiou6, Eleni Papanicolaou5.   

Abstract

We describe the case of a 32-year-old male with previous history of subacute cutaneous lupus erythematosus (SCLE) who presented with arthritis followed by a unilateral lower-limb sensorimotor impairment, without biochemical or immunological marker abnormalities. Our patient currently satisfies only three of the systemic lupus international collaborating clinics criteria. Management of such patients is challenging due to lack of examples in the literature, with this case being the first described where a seronegative patient with SCLE demonstrated neurological involvement. A brief review of the available literature is included.

Entities:  

Keywords:  Dunbar syndrome; Neuropathy; SLICC; Subacute cutaneous lupus erythematosus; Systemic lupus erythematosus

Mesh:

Year:  2016        PMID: 27888319     DOI: 10.1007/s00296-016-3611-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  13 in total

1.  Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period.

Authors:  A Oomatia; H Fang; M Petri; J Birnbaum
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

2.  Clinical and electrophysiological characteristics of symmetric polyneuropathy in a cohort of systemic lupus erythematosus patients.

Authors:  R Jasmin; S Sockalingam; L P Ramanaidu; K J Goh
Journal:  Lupus       Date:  2014-09-24       Impact factor: 2.911

3.  Thalidomide-induced orofacial neuropathy.

Authors:  Cynthia O Anyanwu; Campbell L Stewart; Victoria P Werth
Journal:  J Clin Rheumatol       Date:  2014-10       Impact factor: 3.517

Review 4.  Diagnosis and therapeutic options for peripheral vasculitic neuropathy.

Authors:  Franz Blaes
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-04       Impact factor: 5.346

5.  Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.

Authors:  C M Grönhagen; C M Fored; F Granath; F Nyberg
Journal:  Br J Dermatol       Date:  2011-05-17       Impact factor: 9.302

6.  Evoked potential study and radiological findings in patients with systemic lupus erythematosus.

Authors:  B Fierro; F Brighina; L Amico; A Aloisio; D Buffa; G Caravaglios; V La Bua; L Manfrè; M Oliveri; O Daniele
Journal:  Electromyogr Clin Neurophysiol       Date:  1999 Jul-Aug

Review 7.  Mononeuritis multiplex in systemic lupus erythematosus: response to pulse intravenous cyclophosphamide.

Authors:  V M Martinez-Taboada; R B Alonso; J Armona; J L Fernandez-Sueiro; C Gonzalez Vela; V Rodriguez-Valverde
Journal:  Lupus       Date:  1996-02       Impact factor: 2.911

8.  A case series of 48 patients treated with thalidomide.

Authors:  Sean D Doherty; Sylvia Hsu
Journal:  J Drugs Dermatol       Date:  2008-08       Impact factor: 2.114

9.  Patient with terbinafine-induced subacute cutaneous lupus erythematosus followed by thalidomide-induced orofacial neuropathy; Beta blocker use, hypertension, and the risk of psoriasis; eczematous reaction to intravenous immunoglobulin; nicolau syndrome after intra-articular glucocorticoid injection; troponin leak associated with drug-induced methemoglobinemia.

Authors:  Michael A Mancano
Journal:  Hosp Pharm       Date:  2015-01

Review 10.  Cutaneous lupus erythematosus: An update.

Authors:  Carina M Grönhagen; Filippa Nyberg
Journal:  Indian Dermatol Online J       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.